PDL BioPharma, Inc. Total Assets

Total Assets of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Total Assets growth rates and interactive chart. Total assets are the sum of all current and noncurrent assets and must equal the sum of total liabilities and stockholders' equity combined. In the accounting industry, assets are defined as anything that a business owns, has value, and can be converted to cash.


Highlights and Quick Summary

  • Total Assets for the quarter ending December 30, 2020 was $0 (a -100.0% decrease compared to previous quarter)
  • Year-over-year quarterly Total Assets decreased by -100.0%
  • Annual Total Assets for 2020 was $0 (a -100.0% decrease from previous year)
  • Annual Total Assets for 2019 was $716 Million (a -25.69% decrease from previous year)
  • Annual Total Assets for 2018 was $964 Million (a -22.47% decrease from previous year)
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Total Assets of PDL BioPharma, Inc.

Most recent Total Assetsof PDLI including historical data for past 10 years.

Interactive Chart of Total Assets of PDL BioPharma, Inc.

PDL BioPharma, Inc. Total Assets for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $0.0 $520.66 $659.8 $0.0
2019 $717.21 $865.15 $890.46 $923.53 $716.12
2018 $963.74 $984.43 $946.0 $1,100.4 $963.74
2017 $1,243.12 $1,223.84 $1,301.97 $1,237.77 $1,243.12
2016 $1,215.39 $1,216.07 $1,049.19 $1,055.38 $1,215.39
2015 $1,012.21 $1,020.6 $995.54 $1,114.13 $1,012.21
2014 $962.35 $979.87 $916.41 $852.58 $962.35
2013 $543.96 $429.67 $401.42 $312.81 $543.96
2012 $279.97 $249.9 $259.83 $234.96 $279.97
2011 $269.47 $270.53 $284.26 $248.7 $269.47
2010 $316.67 $257.51 $271.53 $316.67

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.